Gastro Esophageal Reflux Disease Drug and Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Gastro Esophageal Reflux Disease Drug and Devices market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Gastro Esophageal Reflux Disease Drug and Devices market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Gastro Esophageal Reflux Disease Drug and Devices market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Gastro Esophageal Reflux Disease Drug and Devices market segmented into
- Drugs
- Devices
- Drugs Treatment
- Surgical Treatment
- Minimally Invasive Treatment
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Endogastric Solutions
- Medigus
- Medtronic
- Carbon Medical technologies
- Johnson & Johnson
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL GASTRO ESOPHAGEAL REFLUX DISEASE DRUG AND DEVICES INDUSTRY
2.1 Summary about Gastro Esophageal Reflux Disease Drug and Devices Industry
2.2 Gastro Esophageal Reflux Disease Drug and Devices Market Trends
2.2.1 Gastro Esophageal Reflux Disease Drug and Devices Production & Consumption Trends
2.2.2 Gastro Esophageal Reflux Disease Drug and Devices Demand Structure Trends
2.3 Gastro Esophageal Reflux Disease Drug and Devices Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Drugs
4.2.2 Devices
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Drugs Treatment
4.3.2 Surgical Treatment
4.3.3 Minimally Invasive Treatment
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Drugs
5.2.2 Devices
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Drugs Treatment
5.3.2 Surgical Treatment
5.3.3 Minimally Invasive Treatment
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Drugs
6.2.2 Devices
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Drugs Treatment
6.3.2 Surgical Treatment
6.3.3 Minimally Invasive Treatment
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Drugs
7.2.2 Devices
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Drugs Treatment
7.3.2 Surgical Treatment
7.3.3 Minimally Invasive Treatment
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Drugs
8.2.2 Devices
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Drugs Treatment
8.3.2 Surgical Treatment
8.3.3 Minimally Invasive Treatment
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Drugs
9.2.2 Devices
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Drugs Treatment
9.3.2 Surgical Treatment
9.3.3 Minimally Invasive Treatment
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Endogastric Solutions
10.1.2 Medigus
10.1.3 Medtronic
10.1.4 Carbon Medical technologies
10.1.5 Johnson & Johnson
10.2 Gastro Esophageal Reflux Disease Drug and Devices Sales Date of Major Players (2017-2020e)
10.2.1 Endogastric Solutions
10.2.2 Medigus
10.2.3 Medtronic
10.2.4 Carbon Medical technologies
10.2.5 Johnson & Johnson
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL GASTRO ESOPHAGEAL REFLUX DISEASE DRUG AND DEVICES INDUSTRY
2.1 Summary about Gastro Esophageal Reflux Disease Drug and Devices Industry
2.2 Gastro Esophageal Reflux Disease Drug and Devices Market Trends
2.2.1 Gastro Esophageal Reflux Disease Drug and Devices Production & Consumption Trends
2.2.2 Gastro Esophageal Reflux Disease Drug and Devices Demand Structure Trends
2.3 Gastro Esophageal Reflux Disease Drug and Devices Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Drugs
4.2.2 Devices
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Drugs Treatment
4.3.2 Surgical Treatment
4.3.3 Minimally Invasive Treatment
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Drugs
5.2.2 Devices
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Drugs Treatment
5.3.2 Surgical Treatment
5.3.3 Minimally Invasive Treatment
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Drugs
6.2.2 Devices
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Drugs Treatment
6.3.2 Surgical Treatment
6.3.3 Minimally Invasive Treatment
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Drugs
7.2.2 Devices
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Drugs Treatment
7.3.2 Surgical Treatment
7.3.3 Minimally Invasive Treatment
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Drugs
8.2.2 Devices
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Drugs Treatment
8.3.2 Surgical Treatment
8.3.3 Minimally Invasive Treatment
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Drugs
9.2.2 Devices
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Drugs Treatment
9.3.2 Surgical Treatment
9.3.3 Minimally Invasive Treatment
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Endogastric Solutions
10.1.2 Medigus
10.1.3 Medtronic
10.1.4 Carbon Medical technologies
10.1.5 Johnson & Johnson
10.2 Gastro Esophageal Reflux Disease Drug and Devices Sales Date of Major Players (2017-2020e)
10.2.1 Endogastric Solutions
10.2.2 Medigus
10.2.3 Medtronic
10.2.4 Carbon Medical technologies
10.2.5 Johnson & Johnson
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Gastro Esophageal Reflux Disease Drug and Devices Product Type Overview
2.Table Gastro Esophageal Reflux Disease Drug and Devices Product Type Market Share List
3.Table Gastro Esophageal Reflux Disease Drug and Devices Product Type of Major Players
4.Table Brief Introduction of Endogastric Solutions
5.Table Brief Introduction of Medigus
6.Table Brief Introduction of Medtronic
7.Table Brief Introduction of Carbon Medical technologies
8.Table Brief Introduction of Johnson & Johnson
9.Table Products & Services of Endogastric Solutions
10.Table Products & Services of Medigus
11.Table Products & Services of Medtronic
12.Table Products & Services of Carbon Medical technologies
13.Table Products & Services of Johnson & Johnson
14.Table Market Distribution of Major Players
15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
17.Table Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (Million USD) by Region 2021f-2026f
18.Table Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (Million USD) Share by Region 2021f-2026f
19.Table Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (Million USD) by Demand 2021f-2026f
20.Table Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Gastro Esophageal Reflux Disease Drug and Devices Product Type Overview
2.Table Gastro Esophageal Reflux Disease Drug and Devices Product Type Market Share List
3.Table Gastro Esophageal Reflux Disease Drug and Devices Product Type of Major Players
4.Table Brief Introduction of Endogastric Solutions
5.Table Brief Introduction of Medigus
6.Table Brief Introduction of Medtronic
7.Table Brief Introduction of Carbon Medical technologies
8.Table Brief Introduction of Johnson & Johnson
9.Table Products & Services of Endogastric Solutions
10.Table Products & Services of Medigus
11.Table Products & Services of Medtronic
12.Table Products & Services of Carbon Medical technologies
13.Table Products & Services of Johnson & Johnson
14.Table Market Distribution of Major Players
15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
17.Table Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (Million USD) by Region 2021f-2026f
18.Table Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (Million USD) Share by Region 2021f-2026f
19.Table Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (Million USD) by Demand 2021f-2026f
20.Table Global Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Endogastric Solutions 2017-2020e
66.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Medigus 2017-2020e
67.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Medtronic 2017-2020e
68.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Carbon Medical technologies 2017-2020e
69.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
70.
1.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Gastro Esophageal Reflux Disease Drug and Devices Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Devices Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Drugs Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Surgical Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Minimally Invasive Treatment Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Endogastric Solutions 2017-2020e
66.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Medigus 2017-2020e
67.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Medtronic 2017-2020e
68.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Carbon Medical technologies 2017-2020e
69.Figure Gastro Esophageal Reflux Disease Drug and Devices Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
70.
